Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Keiyo Gas Co., Ltd. (9539.T)
Ichikawa, JP
Keiyo Gas Co., Ltd., together with its subsidiaries, engages in the production, supply, and sale of gas in Japan. The company operates through Energy, Life Services, and Real Estate segments. It is also involved in the sale of gas equipment; and provision of gas construction and fitting services. The company provides its services to residential, commercial, industrial, and other customers. In addition, it engages in the sale of electricity; gas construction activities; and real estate rentals and other related activities. Keiyo Gas Co., Ltd. was incorporated in 1926 and is headquartered in Ichikawa, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.38% | -2.93% | +3.34% | -2.16% | +16.74% | +14.48% | +10.93% | +63.13% | +27.30% | +86.30% | +172.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+1.8% Q1'26: +0.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+97.8% ★ Q1'26: +50.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+1.0% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.3% Q1'26: +9.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.5% Q1'26: +8.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.20× Q1'26: 1.33× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 1/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 1/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 1/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 1/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 1/5 | 4/5 | 2/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kazuki Miura | Managing Executive Officer & Director | — | male |
| Koichi Kuno | Senior Managing Executive Officer & Director | — | male |
| Noboru Oishi | Senior Managing Executive Officer & Director | — | male |
| Shinichi Niwa | Managing Executive Officer | — | — |
| Takahiro Sakane | Group Manager of Accounting Department | — | — |
| Takashi Eguchi | President & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 9539.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
